These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21750550)

  • 1. In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
    Adhim Z; Matsuoka T; Bito T; Shigemura K; Lee KM; Kawabata M; Fujisawa M; Nibu K; Shirakawa T
    Br J Cancer; 2011 Jul; 105(3):393-402. PubMed ID: 21750550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
    Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M
    Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo.
    Kitagawa K; Shigemura K; Ishii A; Nakashima T; Matsuo H; Takahashi Y; Omura S; Nakanishi J; Fujisawa M
    Sci Rep; 2021 Apr; 11(1):9217. PubMed ID: 33911182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progression.
    Kitagawa K; Shigemura K; Sung SY; Chen KC; Huang CC; Chiang YT; Liu MC; Huang TW; Yamamichi F; Shirakawa T; Fujisawa M
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2261-2271. PubMed ID: 31367836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
    Fujii R; Imanishi Y; Shibata K; Sakai N; Sakamoto K; Shigetomi S; Habu N; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Kameyama K; Fujii M; Ogawa K
    J Exp Clin Cancer Res; 2014 May; 33(1):40. PubMed ID: 24887090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
    Behari J; Zeng G; Otruba W; Thompson MD; Muller P; Micsenyi A; Sekhon SS; Leoni L; Monga SP
    J Hepatol; 2007 May; 46(5):849-57. PubMed ID: 17275129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
    Saito T; Tamura D; Asano R
    Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells.
    Hänze J; Henrici M; Hegele A; Hofmann R; Olbert PJ
    BMC Cancer; 2013 Dec; 13():589. PubMed ID: 24325461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
    Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
    J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies.
    St John MA; Wang G; Luo J; Dohadwala M; Hu D; Lin Y; Dennis M; Lee JM; Elashoff D; Lawhon T; Zaknoen SL; Burrows FJ; Dubinett SM
    Br J Cancer; 2012 Aug; 107(4):707-12. PubMed ID: 22828609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methyl-D-tryptophan potentiates TGF-β-induced epithelial-mesenchymal transition in T24 human bladder cancer cells.
    Brito RB; Malta CS; Souza DM; Matheus LH; Matos YS; Silva CS; Ferreira JM; Nunes VS; França CM; Dellê H
    PLoS One; 2015; 10(8):e0134858. PubMed ID: 26267811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
    Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo.
    Shigemura K; Shirakawa T; Wada Y; Kamidono S; Fujisawa M; Gotoh A
    Urology; 2005 Dec; 66(6):1239-44. PubMed ID: 16360450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J; Yuan J; Li L; Liu H; Qin R; Qin W; Chen B; Wang H; Wu K
    Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.